← All posts

Five EHR Reports Every FQHC CEO Should Run Before October

Your EHR contains more operational intelligence than most FQHC leaders ever extract from it. The clinical side gets used daily. The operational side — the data that tells you whether your health center is healthy — sits untouched in most organizations.

Here are five reports you should run this quarter. Each one reveals a problem that is costing you money, compliance risk, or patient outcomes right now.

1. The Payer Mix Drift Report

Pull your payer mix by month for the last 12 months. Plot Medicaid, Medicare, commercial, sliding fee, and self-pay as a percentage of total encounters.

What to look for: Is your Medicaid percentage declining while self-pay is rising? That is coverage churn happening in real time. If the lines are diverging by more than 2-3 percentage points per quarter, patients are losing coverage and your front desk is not catching it at check-in.

Why it matters now: With Medicaid work requirements starting January 2027, this trend will accelerate. You need a baseline to measure the impact and justify the resources you will need to manage it.

2. The No-Show Pattern Report

Run your no-show rate by provider, by day of week, and by time slot for the last 6 months. Most EHRs can segment this with basic reporting tools.

What to look for: Patterns. If Dr. Smith has a 22% no-show rate on Monday mornings but 8% on Wednesday afternoons, that is not a patient problem — it is a scheduling problem. If one clinic site runs 18% no-shows while another runs 9%, there is something different about access, transportation, or patient experience at those locations.

Why it matters: Every no-show is a lost PPS encounter. A provider with 20 slots per day and a 15% no-show rate is losing 3 encounters daily — roughly $570 per day or $142,500 annually at a $190 PPS rate. Before you hire another provider, fix the no-show problem you already have.

3. The Chronic Care Gap Report

Identify all patients with chronic conditions (diabetes, hypertension, asthma, depression) who have not had a visit in 90+ days. Segment by insurance status.

What to look for: Two things. First, the raw number — if 30% of your diabetic patients are overdue for care, your quality metrics are going to suffer and your UDS data will reflect it. Second, the insurance breakdown — are the patients falling off disproportionately uninsured or recently-lost-coverage? That tells you coverage churn is driving care gaps, not just patient behavior.

Why it matters: HRSA site visits increasingly focus on quality metrics and care continuity. A chronic care gap report is also your best input for a medical frailty documentation initiative — every chronically ill patient on that list who has Medicaid may need a medical frailty exemption documented before January 2027.

4. The Provider Productivity Variance Report

Compare encounters per provider per day across your clinical team. Include both scheduled and walk-in encounters. Look at the data monthly for the last 6 months.

What to look for: Variance. If your highest-producing provider sees 22 patients per day and your lowest sees 12, that gap is not explained by panel complexity alone. It points to workflow differences, support staff allocation, or scheduling template issues that are costing you real money.

Why it matters: The FQHC workforce shortage is real, but many health centers have untapped capacity in their existing teams. Before requesting additional FTEs, understand whether your current providers are operating at capacity or being constrained by workflow problems you can fix.

5. The 340B Capture Leakage Report

Cross-reference prescriptions written by your 340B-eligible providers against where those prescriptions were filled. How many went to your in-house pharmacy versus external pharmacies?

What to look for: Your capture rate. If your in-house pharmacy captures less than 75% of eligible scripts, every percentage point of improvement is direct 340B savings. A 5,000-prescription FQHC that improves capture rate from 60% to 80% could recover $150,000 to $300,000 annually depending on drug mix.

Why it matters: With contract pharmacy restrictions tightening, in-house capture is your most reliable path to 340B savings. This report tells you exactly how much money is walking out the door — and it is usually more than anyone expects.

The Compound Effect

These five reports do not exist in isolation. Coverage churn (Report 1) drives chronic care gaps (Report 3) which worsens quality metrics. No-show patterns (Report 2) mask provider capacity issues (Report 4). And all of it affects your 340B capture rate (Report 5) because patients who lose coverage, miss appointments, or go elsewhere take their prescriptions with them.

Run these reports once. Set them to auto-generate monthly. Share them with your leadership team. The FQHC leaders who make data-driven decisions are the ones who see problems before they become crises.